Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease

Clinical trial NCT06797011 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06797011
Sponsor: Institute of Liver and Biliary Sciences, India
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Drug Induced Liver Injury Chronic Liver Disease

Start date: 2025-01-25
Primary completion: 2026-01-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.